Etest Voriconazole 0.002-32 Ug/ml
K082534 is the FDA 510(k) clearance record for ETEST VORICONAZOLE 0.002-32 UG/ML, a class II device, cleared for Ab Biomerieux on under FDA product code NGZ (Susceptibility Test Plate, Antifungal). FDA's definition for product code NGZ reads: "The device is an in vitro diagnostic device intended for use in determining quantitative susceptibility of Candida species to various antifungal agents diluted in varying concentration in a microtiter plate format". FDA records list 2 510(k) clearances for Ab Biomerieux, from to . As of , FDA records show no recalls naming K082534.
Clearance record
- Decision date
- Received
- (426 days to decision)
- Product code
- NGZ Susceptibility Test Plate, Antifungal
- Regulation
- 21 CFR 866.1640
- Device class
- Class II
- Review panel
- Microbiology
- Applicant
- Ab Biomerieux Dalvagen 10, Solna, SE
- 510(k) summary
- Statement
- Third party review
- No
Clearances, product code NGZ
Trailing 12 monthsFDA records hold no clearances under product code NGZ in the trailing twelve months.
Show the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
